Literature DB >> 1745708

The Hillside Akathisia Scale: a reliability comparison of the English and German versions.

W W Fleischhacker1, C H Miller, P Schett, C Barnas, H Ehrmann.   

Abstract

Akathisia usually consists of two components, subjective restlessness and typical movements such as shuffling of the legs, pacing, shifting weight from one leg to the other, and rocking movements of the trunk. The ability to measure akathisia reliably is essential for the assessment of treatments for akathisia and for the evaluation of drug-induced side effects in general. To date, investigators have generally used self-constructed assessment scales without reporting data about reliability or validity. The Hillside Akathisia Scale (HAS) has two subjective and three objective items for which anchored rating points are provided. Reliability was 0.89 for the HAS total score. Reliability for rating subjective symptoms ranged from 0.86 to 0.92, and the objective scores ranged from 0.51 to 0.89. The correlation between HAS and a global assessment of akathisia (modified CGI) was 0.87. These values compare favorably with the original report on the scale indicating that the Hillside Akathisia Scale can validly quantify akathisia with a satisfactory degree of interrater reliability.

Entities:  

Mesh:

Year:  1991        PMID: 1745708     DOI: 10.1007/bf02316879

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  19 in total

1.  Treatment of neuroleptic induced akathisia with the 5-HT2 antagonist ritanserin.

Authors:  C H Miller; W W Fleischhacker; H Ehrmann; J M Kane
Journal:  Psychopharmacol Bull       Date:  1990

2.  The Hillside Akathisia Scale: a new rating instrument for neuroleptic-induced akathisia.

Authors:  W W Fleischhacker; K J Bergmann; R Perovich; L K Pestreich; M Borenstein; J A Lieberman; J M Kane
Journal:  Psychopharmacol Bull       Date:  1989

3.  Methysergide-induced akathisia.

Authors:  C Bernick
Journal:  Clin Neuropharmacol       Date:  1988-02       Impact factor: 1.592

4.  A rating scale for drug-induced akathisia.

Authors:  T R Barnes
Journal:  Br J Psychiatry       Date:  1989-05       Impact factor: 9.319

5.  Lithium-induced akathisia.

Authors:  J F Patterson
Journal:  J Clin Psychopharmacol       Date:  1988-12       Impact factor: 3.153

6.  Propranolol in the treatment of neuroleptic-induced akathisia (NIA) in schizophrenics: a double-blind, placebo-controlled study.

Authors:  M S Kramer; R A Gorkin; C DiJohnson; P Sheves
Journal:  Biol Psychiatry       Date:  1988-11       Impact factor: 13.382

7.  Comparison of propranolol, sotalol, and betaxolol in the treatment of neuroleptic-induced akathisia.

Authors:  B Dupuis; J Catteau; J P Dumon; C Libert; H Petit
Journal:  Am J Psychiatry       Date:  1987-06       Impact factor: 18.112

8.  The clinical phenomenon of akathisia.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-08       Impact factor: 10.154

9.  Clinical characteristics of akathisia. A systematic investigation of acute psychiatric inpatient admissions.

Authors:  W M Braude; T R Barnes; S M Gore
Journal:  Br J Psychiatry       Date:  1983-08       Impact factor: 9.319

10.  Akathisia with haloperidol and thiothixene.

Authors:  T Van Putten; P R May; S R Marder
Journal:  Arch Gen Psychiatry       Date:  1984-11
View more
  3 in total

Review 1.  Managing antipsychotic-induced acute and chronic akathisia.

Authors:  C H Miller; W W Fleischhacker
Journal:  Drug Saf       Date:  2000-01       Impact factor: 5.606

Review 2.  Antipsychotic-induced akathisia in delirium: A systematic review.

Authors:  Fernando Espi Forcen; Konstantina Matsoukas; Yesne Alici
Journal:  Palliat Support Care       Date:  2015-06-19

3.  Extrapyramidal side effects of clozapine and haloperidol.

Authors:  M Kurz; M Hummer; H Oberbauer; W W Fleischhacker
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.